This trial is looking at how physical activity affects breast cancer patients by looking at changes in the tumor, how much oxygen it gets, and the levels of circulating tumor DNA and exerkines.
4 Primary · 5 Secondary · Reporting Duration: baseline or before cardiopulmonary exercise (CPET), immediately after CPET (an average of 12 min following baseline), 30 min following CPET, and 2 hours following CPET
Awards & Highlights
1 Treatment Group
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: Acute Exercise · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 80 · Female Participants · 14 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this trial permit participants of all ages, or are there age restrictions?
"This trial is open to individuals aged 18 or older, but no more than 80 years old." - Anonymous Online Contributor
Are there any eligibility criteria which would disqualify me from participating in this trial?
"The prerequisites for being accepted into this clinical trial mandate that patients are between 18 and 80 years old and have been diagnosed with breast cancer. A total of 30 enrollees will be admitted to the experiment." - Anonymous Online Contributor
How many subjects are participating in this clinical trial?
"Affirmative. The clinicaltrial.gov website reveals that this medical trial is presently looking for 30 test subjects across one site, and it was initially posted on July 29th 2022 with the most recent edit made on August 17th of the same year." - Anonymous Online Contributor
Are there any vacancies available for participants of this research endeavor?
"Affirmative. Clinicaltrials.gov records specify that this medical experiment is currently seeking participants; it was initially posted on July 29th 2022 and its details have been revised as recently as August 17th of the same year. 30 subjects need to be identified from a single site for inclusion in the research study." - Anonymous Online Contributor
What goals is this research study attempting to achieve?
"This trial's main objective is to observe changes in oxy-hemoglobin levels over four periods: the baseline, 12 minutes post-baseline, 30 minutes post-baseline and two hours post-baseline. In addition to this primary outcome, secondary objectives also encompass tracking alterations in ctDNA level, TGF-β concentration and S1P presence across these same points of time." - Anonymous Online Contributor